A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.

Date publication

septembre 2017

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric , Pr PEIFFERT Didier , Dr RIOS Maria

Tous les auteurs :
Nesseler JP, Salleron J, Rios M, Nickers P, Marchal F, Brocard F, Peiffert D, Vogin G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28951009

Résumé

To evaluate the efficacy and tolerance of adjuvant concurrent chemoradiation (CCRT) as treatment of grade 2 and 3 (G2-3) localized extremity soft tissue sarcomas (STS) by comparing CCRT with standard adjuvant radiation therapy (RT).

Mots clés

Adjuvant treatment, Concurrent chemoradiotherapy, Local control, Soft tissue sarcoma, Toxicity

Référence

Radiother Oncol. 2017 Sep;: